From Canva to Chronic Care: Human Health’s $8.4M Bet on a ‘Radar for the Lungs’
Human offers a personalized healthcare platform that enables users to track their symptoms and treatments for chronic conditions, providing actionable insights to improve health management.
Human Health, the startup co-founded by former Canva leaders Georgia Vidler and Kate Lambridis, just announced an $8.4 million partnership with Diag-Nose.io to reimagine how chronic respiratory illnesses are diagnosed and treated. Their joint platform, RhinoMAP, is a powerful new tool that blends AI, biomarker analysis, and real-time patient data—essentially a radar system for the lungs.
Vidler, who helped scale Canva during its hypergrowth years, said the idea for Human was deeply personal: both she and Lambridis had family members struggle through confusing chronic diagnoses and fragmented care. Now, with 200,000+ users already on Human’s symptom-tracking app, the team is scaling a system that prioritizes personalized, precision care over outdated one-size-fits-all approaches.
Diagnosing the Invisible
At the core of the partnership is Diag-Nose.io’s AI-powered biomarker platform, which analyzes nasal fluid samples to give physicians a real-time view of inflammation in the respiratory system. According to CEO Eldin Rostom, who studied at Stanford and now leads Diag-Nose.io, the goal is to cut down on trial-and-error treatment cycles—especially for expensive biologics, where half of patients don’t see results.
“But you can measure lung biology all the way to the nose,” said Rostom. “It’s a unified system. Most people are biologically different, and unless we’re looking at individuals on a biological level, we’re only telling half the story.”
Backed by Tech and Government
The project received $3 million from the Australian government’s CRC-P grant program, with support from Monash University, Mater Research, ENT Clinic Melbourne, and Manse Medical. Human is also backed by Skip Capital, the family office of Atlassian co-founder Scott Farquhar and Kim Jackson, as well as early-stage VC AirTree.
“We love backing innovative companies solving big, global challenges,” said Jackson. “Our investment in Human is a great example.”
Beyond the Lungs
Vidler sees this as just the beginning. Human Health’s long-term goal is to build a precision health operating system—a platform that helps people manage multiple chronic conditions, recognizing the widespread issue of comorbidity and the inefficiencies of population-based care.
“The faster you can get someone the right treatment that actually helps them, the cheaper it’s going to be,” she said. “It’s a rare and powerful convergence of science, technology, and government. Silicon Valley does this every day. It’s about time Australia did too.”
Read more on The Australian
Listen to Daniel Faddoul with Alberto Escarlate on the Venture Everywhere podcast: Listen Up with Auditive. Now on Apple & Spotify. Check out to all our past episodes here!
